Sanofi and Regeneron do not anticipate carrying out further research on Kevzara in COVID-19
Rybelsus is the world’s first and only oral GLP-1 receptor agonist
Clinical development of AZD1222 is progressing globally with late-stage clinical trials ongoing in the UK, Brazil and South […]
The Phase II/III COMET-ICE study will assess safety and efficacy of antibody treatment in preventing hospitalisation due to […]
The EC has cleared its use for the treatment of extensive-stage small cell lung cancer
Updated Date: Mon, 24 Aug 2020 00:00:00 EDT
Updated Date: Mon, 24 Aug 2020 00:00:00 EDT
Improving FDA’s COVID-19 vaccine authorization and approval process: Lessons from hydroxychloroquine
In a new article, researchers propose reforms that the U.S. Food and Drug Administration (FDA) could implement to […]
Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family for the first time; its malfunction […]
HCA|Organoid is a new EU research project that combines single-cell profiling and organoid technology to validate organoids as […]